Terry J. Smith and Raymond Douglas, Michigan Medicine – University of Michigan (IMAGE)
Caption
Research led Terry J. Smith, M.D., and Raymond Douglas, M.D., Ph.D., while at the University of Michigan Kellogg Eye Center, shows success of teprotumumab in safely reducing disfiguring eye symptoms of Graves' eye disease.
Credit
University of Michigan Kellogg Eye Center
Usage Restrictions
None
License
Licensed content